CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the second quarter of 2024. More
Articles
KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024
KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the first quarter of 2024. More
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q1 2024
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. More
PEPG Stock Earnings: PepGen Beats EPS for Q1 2024
PEPG stock results show that PepGen beat analyst estimates for earnings per share the first quarter of 2024. More
ANRO Stock Earnings: Alto Neuroscience Misses EPS for Q1 2024
ANRO stock results show that Alto Neuroscience missed analyst estimates for earnings per share the first quarter of 2024. More
MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
MGX stock results show that Metagenomi missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q1 2024
KYTX stock results show that Kyverna Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
